Results 21 to 30 of about 85,877 (261)

Household screening and multidrug-resistant tuberculosis [PDF]

open access: yes, 2010
Of the estimated half a million people who develop multidrug resistant (MDR) tuberculosis each year, less than 7% are diagnosed and only 1 in 5 of these have access to eff ective treatment.1 To control this epidemic, dramatically increased efforts are ...
Becerra   +9 more
core   +2 more sources

SHORT-TERM CHEMOTHERAPY REGIMEN OF MULTIDRUG-RESISTANT TUBERCULOSIS IN THE KYRGYZ REPUBLIC

open access: yesПаёми Сино, 2018
Objective: To study the clinical course of tuberculosis (TB) with multiple drug resistance (MDR) in the treatment of short-term courses recommended by the WHO.
E.V. ZHDANOVA, G.K. TURDUMAMBETOVA
doaj   +1 more source

Factors associated with multidrug-resistant tuberculosis in Guinea Bissau: January 1, 2018 - December 31, 2019

open access: yesInternational Journal of Infectious Diseases, 2022
Purpose: Multidrug-resistant tuberculosis continues to cause a public health crisis and remains a threat to health security. Drug resistance to anti-tuberculosis drugs remains a major public health problem that compromises the successes in the fight ...
P.K. Yanogo, A.L. Papique, N. Meda
doaj   +1 more source

Detecting Mutations in the Mycobacterium tuberculosis Pyrazinamidase Gene pncA to Improve Infection Control and Decrease Drug Resistance Rates in Human Immunodeficiency Virus Coinfection. [PDF]

open access: yes, 2016
Hospital infection control measures are crucial to tuberculosis (TB) control strategies within settings caring for human immunodeficiency virus (HIV)-positive patients, as these patients are at heightened risk of developing TB.
Bangsberg   +41 more
core   +2 more sources

Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis [PDF]

open access: yes, 2012
BACKGROUND: Paediatric multidrug-resistant (MDR) tuberculosis is a public health challenge of growing concern, accounting for an estimated 15% of all global cases of MDR tuberculosis. Clinical management is especially challenging, and recommendations are
Abubakar   +42 more
core   +2 more sources

Detection of multidrug-resistant Mycobacterium tuberculosis strains isolated in Brazil using a multimarker genetic assay for katG and rpoB genes

open access: yesBrazilian Journal of Infectious Diseases, 2016
Multidrug-resistant tuberculosis (MDRTB) is a serious world health problem that limits public actions to control tuberculosis, because the most used anti-tuberculosis first-line drugs fail to stop mycobacterium spread.
Luita Nice Café Oliveira   +5 more
doaj   +1 more source

A public health approach to palliative care in the response to drug resistant TB: an ethnographic study in Bengaluru, India. [PDF]

open access: yes, 2018
BACKGROUND: The treatment of Multidrug-Resistant Tuberculosis represents one of the most significant challenges to global health. Despite guidance on improving treatment outcomes, there is little focus on how to support individuals in their suffering ...
Asgr, Rahul   +3 more
core   +2 more sources

Spatial patterns of multidrug-resistant tuberculosis: correlation with sociodemographic variables and type of notification [PDF]

open access: yesRevista Brasileira de Enfermagem, 2020
Objective: Correlate the cases of multidrug-resistant tuberculosis and its spatial patterns with the type of notification and sociodemographic variables.
Ingrid Bentes Lima   +6 more
doaj   +3 more sources

Use of the GenoType MTBDRplus for early diagnosis of multidrug-resistant tuberculosis

open access: yesZaporožskij Medicinskij Žurnal, 2017
The type of diagnostics methods and their duration, loss of time for the appointment of the optimal treatment are the major categories of factors that influence on multidrug resistant tuberculosis treatment effectiveness.
O. M. Raznatovska   +4 more
doaj   +1 more source

New and Improved Diagnostics for Detection of Drug-Resistant Pulmonary Tuberculosis. [PDF]

open access: yes, 2011
PURPOSE OF REVIEW: Tuberculosis (TB) remains a global emergency and continues to kill 1.7 million people globally each year. Drug-resistant TB is now well established throughout the world and most TB patients are not being screened for drug resistance ...
Affolabi   +41 more
core   +1 more source

Home - About - Disclaimer - Privacy